Skip to main content

Navigation group

Type at least 3 characters
1,205 articles

Articles

Original Research

Published on 16 Aug 2021

Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study

in Cardiovascular and Smooth Muscle Pharmacology

  • Giuseppe Armentaro
  • Graziella D’Arrigo
  • Marcello Magurno
  • Alfredo F. Toscani
  • Valentino Condoleo
  • Sofia Miceli
  • Velia Cassano
  • Raffaele Maio
  • Franco Arturi
  • Giovanni Tripepi
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study
Frontiers in Pharmacology
doi 10.3389/fphar.2021.733475
  • 4,743 views
  • 15 citations

Original Research

Published on 26 Jul 2021

Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models

in Cardiovascular and Smooth Muscle Pharmacology

  • Evelyne J. Demkes
  • Steven Wenker
  • Max J. M. Silvis
  • Martijn M. J. van Nieuwburg
  • M. Joyce Visser
  • Marlijn S. Jansen
  • Maike A. D. Brans
  • Evelyn Velema
  • Joost P. G. Sluijter
  • Imo E. Hoefer
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models
Frontiers in Pharmacology
doi 10.3389/fphar.2021.702326
  • 3,385 views
  • 5 citations